Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation
- Resource Type
- Article
- Authors
- Domingo-Domenech, E.; Duarte, R. F.; Boumedil, A.; Onida, F.; Gabriel, I.; Finel, H.; Arcese, W.; Browne, P.; Beelen, D.; Kobbe, G.; Veelken, H.; Arranz, R.; Greinix, H.; Lenhoff, S.; Poiré, X.; Ribera, J. M.; Thompson, J.; Zuckerman, T.; Mufti, G. J.; Cortelezzi, A.; Olavarria, E.; Dreger, P.; Sureda, A.; Montoto, S.
- Source
- Bone Marrow Transplantation; 20210101, Issue: Preprints p1-11, 11p
- Subject
- Language
- ISSN
- 02683369; 14765365
Allogeneic transplantation is a potentially curative option for advanced-stage mycosis fungoides and Sézary syndrome.Advanced-phase disease constitutes the most important prognostic factor for the long term outcome of the patients.The negative impact of the use of unrelated donors needs to be further elucidated.